|Last Price$44.39||Day Change (%)-0.72%|
|Open Price$44.36||Day Change ($)-0.32|
|Day Range44.31–44.95||52-Week Range32.18–44.95|
As of Tue 5/3/2016 6:02:00 PM | USD
Global Human Vaccine Market Growth 11.69% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: GlaxoSmithKline, Merck, Pfizer - Research and Markets
Global Infusion Pumps Market Worth USD 4922 Million by 2025 - Analysis, Technologies & Forecasts Report 2015-2025 - Key Vendors: Baxter , Braun, CareFusion - Research and Markets
Baxalta Supports Research to Raise Awareness of Treatment Burden on Patients during the Sixth Annual World Primary Immunodeficiency Week
Although 2015 may be rocky, both Baxter and Baxalta should see significant margin expansion and growth in the long term, says Morningstar's Karen Andersen.
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Standing out in a good year for stocks.
The diversified health-care firm remains remarkably profitable in tough industries.